Xencor Inc. Stock
Xencor Inc. Stock
There is no change in the price for Xencor Inc. today.
We see a rather positive sentiment for Xencor Inc. with 15 Buy predictions and 2 Sell predictions.
Based on the current price of 9.85 € the target price of 22 € shows a potential of 123.35% for Xencor Inc. which would more than double the current price.
Pros and Cons of Xencor Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xencor Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | 0.000% | 3.141% | -7.944% | -32.993% | -22.441% | -69.599% | -76.659% |
| Iovance Biotherapeutics Inc. | 1.220% | 12.889% | 17.326% | -54.209% | 3.204% | -64.989% | -93.712% |
| United Therapeutics | -0.270% | 1.895% | 2.329% | 16.876% | -4.376% | 70.962% | 181.793% |
| Neurocrine Bioscience | -1.900% | 4.400% | -4.922% | -1.266% | -10.569% | 12.933% | 16.688% |
Comments
Xencor (NASDAQ:XNCR) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its price target raised by analysts at Royal Bank Of Canada from $18.00 to $19.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat